Johnson & Johnson MedTech announces updates to Varipulse, new ultrasound catheter

Johnson & Johnson MedTech (NYSE: JNJ)+ today announced the full commercial release of its NuVision Nav ultrasound catheter.

Additionally, the company announced the introduction of the Varipulse Plus platform. Varipulse Plus represents an update to the existing Varipulse pulsed field ablation (PFA) platform, introducing automated irrigation flow. It builds procedural confidence and reinforces its well-established safety profile.

Johnson & Johnson MedTech said its Varipulse platform is the first PFA technology designed to streamline ablation and mapping through a single integrated workflow with the Carto 3 mapping system. Carto 3 offers 3D heart mapping for electrophysiology procedures, including PFA.

The company said the combination offers enhanced precision, efficiency, and procedural reproducibility for physicians treating patients with AFib.

Sign up for Blog Updates